Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia (Q46641038)
Jump to navigation
Jump to search
scientific article published in April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia |
scientific article published in April 2008 |
Statements
1 reference
Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia (English)
1 reference
Frans Debruyne
1 reference
Arkadij A Gres
1 reference
Dmitrii L Arustamov
1 reference
1 April 2008
1 reference
1 reference
54
1 reference
1
1 reference
170-177
1 reference